Sophia Zoungas's Publications

Zoungas S., Cooper M., Woodward Mark, Williams B., Hillis G., Li Q., Marre M., Thomas M., Pickering R., Chalmers J.
The Relationship Between Levels of Advanced Glycation End-Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes
Journal Article
2015
Diabetes Care
Cass Alan, Zoungas S., Jun M., Hirakawa Y., Hawley C., Toyama T., Pilmore H., Badve S., Lo C, Perkovic Vlado
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease (Protocol)
Journal Article
2015
Cochrane Database of Systematic Reviews
Zoungas S., Glass Parisa, Kengne A., Woodward Mark, Visseren F., Poulter N., Grobbee D., Hamet P., van der Leeuw J., van der Graaf Y.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation
Journal Article
2015
Hypertension
Zoungas S., Cooper M., Woodward Mark, Williams B., Hillis G., Li Q., Marre M., Thomas M., Pickering R., Chalmers J.
Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes
Journal Article
2015
Diabetes Care
Arima Hisatomi, Hirakawa Y., Woodward Mark, Zoungas Sophia, Poulter N., Williams B., Mancia G., Harrap S., Chalmers J., Patel Anushka
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial
Journal Article
2014
Hypertension
Arima Hisatomi, Monaghan H., Joshi Rohina, Zoungas Sophia, Hirakawa Y, Hamet P, Mancia G, Poulter N, Harrap S, Li Q
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Journal Article
2014
New England Journal of Medicine
Kerr P., Polkinghorne K., Teede H., Zoungas Sophia, Lo C., Lui M., Ranasinha S., Nathan D., Zheng H.
Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease
Journal Article
2014
Diabetes Research and Clinical Practice
Zoungas Sophia, Curtis A, McNeil J, Tonkin A
Treatment of dyslipidemias and cardiovascular outcomes: the journey so far. Is this the end for statins?
Journal Article
2014
Clinical Pharmacology and Therapeutics
Zoungas Sophia, Curtis A, McNeil J, Tonkin A
Statins in the elderly: an answered question?
Journal Article
2014
Current Opinion in Cardiology
Arima Hisatomi, Zoungas S., Woodward Mark, Ninomiya T., Hirakawa Y, Cooper M, Hamet P, Mancia G, Poulter N, Harrap S
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial
Journal Article
2014
Diabetes Care
Zoungas Sophia, Curtis A., McNeil J., Tonkin A.
Treatment of dyslipidemia and cardiovascular outcomes: the journey so far--is this the end for statins?
Journal Article
2014
Clinical Pharmacology and Therapeutics
Hillis Graham, Woodward Mark, Zoungas Sophia, Blomster J., Poulter N., Williams B., Mancia G., Harrap S., Li Q., Chalmers J.
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes mellitus.
Journal Article
2014
Diabetes Care
Cooper M., Woodward Mark, Zoungas Sophia, Poulter N., Williams B., Hamet P., Harrap S., Li Q., Heller S., Marre M.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
Journal Article
2014
Diabetologia
Zoungas S., Neal Bruce
Understanding the effects of interventions; assessing cardiovascular outcomes [Invited]
Conference Paper
2013
MSD EADF Meeting
Grobbee D., Stefansdottir G., Knol M., Leufkens H., De Bruin M., Kengne Andre, Woodward Mark, Zoungas Sophia, Chalmers J., Patel Anushka
Erratum to : Intensive glucose control and risk of cancer patients with type 2 diabetes
Journal Article
2013
Diabetologia
Woodward Mark, Zoungas Sophia, Hillis Graham, Blomster J., Marre M., Poulter N., Harrap S., Chalmers J., Chow Clara, Patel Anushka
The Influence Of Physical Activity On Vascular Complications And Mortality In Patients With Type 2 Diabetes Mellitus
Journal Article
2013
Diabetes, Obesity and Metabolism
Zoungas S., Sattar N., Woodward Mark, Welsh P., Poulter N., Williams B., Mancia G., Jun M., Hillis G., Q. Mbiostat Li
The relative and combined ability of high sensitivity cardiac troponin T and N-terminal pro-BNP to predict cardiovascular events and death in patients with type 2 diabetes mellitus
Journal Article
2013
Diabetes Care
Arima Hisatomi, Hirakawa Y., Woodward Mark, Zoungas Sophia, Poulter N., Harrap S., Williams B., Mancia G., Chalmers J., Patel Anushka
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial
Journal Article
2013
Hypertension
Razavian M., Palmer S., Di Micco L., Zoungas Sophia, Webster A., Strippoli G., Pellegrini F., Craig J., Jardine M, Perkovic Vlado
Antiplatelet agents for chronic kidney disease
Journal Article
2013
Cochrane Database of Systematic Reviews
Arima Hisatomi, Zoungas S., Hata Jun, Woodward Mark, ADVANCE Collaborative Group, Poulter N., Glasziou P., Anderson Craig, Hamet P., Williams B.
Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patient with type 2 diabetes: the ADVANCE trial
Journal Article
2013
Circulation

Sophia Zoungas's Publications

The Relationship Between Levels of Advanced Glycation End-Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease (Protocol)

Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation

Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes

Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease

Treatment of dyslipidemias and cardiovascular outcomes: the journey so far. Is this the end for statins?

Statins in the elderly: an answered question?

Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial

Treatment of dyslipidemia and cardiovascular outcomes: the journey so far--is this the end for statins?

The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes mellitus.

Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes

Understanding the effects of interventions; assessing cardiovascular outcomes [Invited]

Erratum to : Intensive glucose control and risk of cancer patients with type 2 diabetes

The Influence Of Physical Activity On Vascular Complications And Mortality In Patients With Type 2 Diabetes Mellitus

The relative and combined ability of high sensitivity cardiac troponin T and N-terminal pro-BNP to predict cardiovascular events and death in patients with type 2 diabetes mellitus

Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial

Antiplatelet agents for chronic kidney disease

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patient with type 2 diabetes: the ADVANCE trial

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country